Infracore SA宣布，已在瑞士证券交易所启动首次公开募股，发行价定为每股54瑞士法郎。此次IPO将提供最多5,643,517股股票。根据2026年第一季度末的数据，这一发行价相对于其资产净值约有5%的折让。Infracore的股票预计将于2026年7月9日左右在瑞士证券交易所开始交易。本次发行完成后，公司的预期总市值将约为8.26亿瑞士法郎。此外，公司现有的主要股东Medical Properties Trust和Aevis Victoria SA在IPO后仍将持有其大量股份。
Infracore SA宣布，已在瑞士证券交易所启动首次公开募股，发行价定为每股54瑞士法郎。此次IPO将提供最多5,643,517股股票。根据2026年第一季度末的数据，这一发行价相对于其资产净值约有5%的折让。Infracore的股票预计将于2026年7月9日左右在瑞士证券交易所开始交易。本次发行完成后，公司的预期总市值将约为8.26亿瑞士法郎。此外，公司现有的主要股东Medical Properties Trust和Aevis Victoria SA在IPO后仍将持有其大量股份。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.